# Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B)

> clinical trial · VERIFIED · 2026-07-09

Status: ACTIVE_NOT_RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Advanced Lymphoma

- Company: National Cancer Institute (NCI)
- Sector: Advanced Lymphoma
- Primary source: https://clinicaltrials.gov/study/NCT04439201

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.